University of Pennsylvania - Perelman Center
Welcome,         Profile    Billing    Logout  
 18 Trials 
23 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kawut, Steven M
PHAR, NCT04071327: Pulmonary Hypertension Association Registry

Recruiting
N/A
3000
US
Pulmonary Hypertension Association, Inc., University of Washington, the Collaborative Health Studies Coordinating Center
Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Hypertension
10/25
10/25
Goldberg, David
ADapt, NCT05369403: A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab

Active, not recruiting
3
120
US
Lebrikizumab, LY3650150, DRM06
Eli Lilly and Company
Atopic Dermatitis
01/24
02/25
PLATyPuS, NCT02315898: Inhaled Tissue Plasminogen Activator for Acute Plastic Bronchitis

Completed
2
40
US
Treatment-inhaled tPA, alteplase, Activase
University of Michigan, Genentech, Inc.
Plastic Bronchitis, Protein-Losing Enteropathies, Healthy
03/21
06/23
NCT04844840: A Study for Safety and Efficacy Evaluation of Various Doses of STP705 in Reducing Keloid Recurrence

Completed
2
29
US
STP705, STP705 Powder for Injection, Placebo
Sirnaomics
Keloid
05/23
05/23
NCT04844983: A Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Patients With isSCC

Completed
2
44
US
STP705, STP705 Powder for Injection, Placebo Saline
Sirnaomics
Squamous Cell Carcinoma in Situ
08/22
12/22
NCT06176768: A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis

Recruiting
2
75
US
LY3972406, Placebo
Eli Lilly and Company
Plaque Psoriasis
04/25
07/25
THINKER-NEXT, NCT04075916: A Trial of Transplanting Hepatitis C Kidneys Into Hepatitis C-Negative Kidney Recipients

Active, not recruiting
2
201
US
Epclusa
University of Pennsylvania, Gilead Sciences, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
End Stage Renal Disease
06/25
01/26
LCN RESCU, NCT05832229: Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

Recruiting
2
256
US
Rosuvastatin, Rosuvastatin 20 mg, Rosuvastatin 10 mg
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), The Cleveland Clinic, Columbia University, Weill Medical College of Cornell University, Duke University, Mayo Clinic, University of Miami, University of Michigan, University of California, San Diego, University of California, San Francisco, LAC+USC Medical Center, Virginia Commonwealth University, National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Cancer Institute (NCI), University of Southern California
Cirrhosis, Cirrhosis, Liver, Cirrhosis Early, Cirrhosis Due to Hepatitis B, Cirrhosis Advanced, Cirrhosis Infectious, Cirrhosis Alcoholic, Cirrhosis Due to Hepatitis C
11/26
11/26
FALD, NCT03430583: Evaluation of Fontan-Associated Liver Disease

Active, not recruiting
N/A
100
Canada, US
MZ101
Mezzion Pharma Co. Ltd, National Heart, Lung, and Blood Institute (NHLBI)
Single Ventricle Heart Disease
06/21
08/21
RELAX, NCT05457322: The Trial: Nonpharmaceutical Intervention for Nocturnal Muscle Cramps

Completed
N/A
99
US
Behavioral intervention one, Behavioral intervention two
University of Michigan
Cramps, Muscle Cramp
08/23
08/23
NCT05358860: Safety and Efficacy of Sofwave Treatment for Acne Scars Appearance Improvement

Completed
N/A
60
US
Sofwave, SUPERB
Sofwave Medical LTD
Acne Scars - Mixed Atrophic and Hypertrophic
12/22
12/22
NCT05882721: Treatment for Improvement of Cellulite Appearance Using Form Applicator

Completed
N/A
60
US
Sofwave
Sofwave Medical LTD
Cellulite
11/23
11/23
NCT05323253: A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma

Recruiting
N/A
86
Canada, US, RoW
DaRT seeds, DaRT
Alpha Tau Medical LTD.
Recurrent Squamous Cell Carcinoma
12/24
12/25
TEST, NCT05260268: Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant

Recruiting
N/A
360
US
TEST Intervention
University of Pennsylvania, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Liver Transplant; Complications, Cirrhosis, End Stage Liver DIsease, Medication Adherence
07/26
01/27
LCN-C, NCT05740358: Liver Cirrhosis Network Cohort Study

Recruiting
N/A
1200
US
Northwestern University, The Cleveland Clinic, Columbia University, Weill Medical College of Cornell University, Duke University, Mayo Clinic, University of Miami, University of Michigan, University of California, San Diego, University of California, San Francisco, LAC+USC Medical Center, Virginia Commonwealth University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Cancer Institute (NCI), University of Southern California, Central Virginia Veterans Healthcare System
Cirrhosis, Cirrhosis, Liver, Cirrhosis Early, Cirrhosis Due to Hepatitis B, Cirrhosis Advanced, Cirrhosis Infectious, Cirrhosis Alcoholic, Cirrhosis, Biliary, Cirrhosis Cryptogenic, Cirrhosis Due to Hepatitis C, Cirrhosis Due to Primary Sclerosing Cholangitis
09/27
09/28
Santangeli, Pasquale
RAAFT-3, NCT04037397: First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment

Completed
3
25
US
Anti Arrhythmics, Pulmonary Vein Isolation performed by Radio Frequency Catheter Ablation
University of Pennsylvania, Biosense Webster, Inc., Texas Cardiac Arrhythmia Research Foundation
Atrial Fibrillation
10/24
10/24
PLEA, NCT04216667: Posterior Wall And Left Atrial Appendage Empiric Electrical Isolation for Non-Paroxysmal Atrial Fibrillation

Terminated
N/A
124
Europe, US, RoW
Catheter ablation
Montefiore Medical Center, Biosense Webster, Inc.
Atrial Fibrillation
06/23
06/23
VTFM, NCT05708131: Outcomes of Functional Substrate Mapping of Ventricular Tachycardia

Recruiting
N/A
70
Europe, US
Mid and South Essex NHS Foundation Trust, Abbott
Ventricular Tachycardia
12/24
12/24
AIM-VT, NCT06138873: Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients With Ischemic Cardiomyopathy

Recruiting
N/A
100
US
Ablation-index guided ventricular tachycardia ablation, Ventricular tachycardia ablation with no AI-guidance
Rush University Medical Center, University of Michigan, Medical University of South Carolina, The Cleveland Clinic, Biosense Webster, Inc.
Ventricular Tachycardia, Ischemic Cardiomyopathy
11/26
11/27
NCT06051994: Ablation-Index Guided Ventricular Tachycardia Ablations

Not yet recruiting
N/A
100
US
AI-guided VA ablation
Rush University Medical Center, Biosense Webster, Inc., University of Michigan, The Cleveland Clinic, Medical University of South Carolina
Ventricular Tachycardia, Ventricular Arrythmia, Cardiomyopathies
11/26
11/27
Patel, Mamta
NCT04740671 / 2020-005364-57: A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD

Completed
3
410
Europe, US, RoW
HLX04-O, ranibizumab
Shanghai Henlius Biotech
Age Related Macular Degeneration
12/24
12/24
Sharkoski, Tiffany
NCT06517186: Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction

Recruiting
N/A
180
US
Northwestern University, National Heart, Lung, and Blood Institute (NHLBI), Massachusetts General Hospital, Brigham and Women's Hospital, Mayo Clinic, Wake Forest University Health Sciences, University of Pennsylvania
Heart Failure, Heart Failure With Preserved Ejection Fraction
06/26
06/26
NCT05873634: HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets

Recruiting
N/A
1000
US
Northwestern University, National Heart, Lung, and Blood Institute (NHLBI), Massachusetts General Hospital, Brigham and Women's Hospital, Mayo Clinic, University of California, Davis, Wake Forest University Health Sciences, University of Pennsylvania
Heart Failure, Heart Failure With Preserved Ejection Fraction
06/26
06/26

Download Options